CORONAVIRUS ALERT: Any symptoms of fever, cough, difficulty breathing AND travel to high risk areas(China, Italy, Iran and South Korea) in last 14 days or if you have been in close contact with someone who has traveled to these areas. NOTIFY YOUR PHYSICIAN IMMEDIATELY! 

After much consideration, and in an effort to protect the well-being of our community, we have made a decision to implement caregiver and visitor limitations at all MOH clinics that include:

  • No Visitors are allowed in the clinics
  • Only 1 caregiver can accompany a patient in the practice if they have no upper respiratory symptoms - upper respiratory symptoms include: a cough, fever of 101.1 and above, nasal congestion, runny nose or sore throat
  • Children age 15 or younger are not allowed in the clinic until further notice 

The health and safety of our MOH patients and staff is our top priority. We recognize that these visitor limitations may cause concerns, so if you feel you have a special circumstance, please notify the front desk so a manager can discuss your situation.Visitors with flu-like symptoms are not permitted to visit our offices in order to protect patients and staff.

The following offices, Wheaton and Germantown have consolidated to our Rockville & Bethesda locations. In addition, our Mt. Airy office has consolidated to our Frederick location.

Learn More - Coronavirus Disease (COVID-19)                   Follow Us on Facebook for MOH Office Information

Immunotherapy

Our team at Maryland Oncology Hematology, along with the thousand physicians of The US Oncology Network, are focused on joining together to shape the future of cancer care. We believe that we can have the greatest impact by bringing the most advanced care to patients in community-based practices, near where patients live and have support systems. This includes offering immunotherapy treatments which are receiving FDA approval and are an important focus for many of the clinical trials now opening for patients.

What is Immunotherapy

Historically, treatment options available for cancer included surgery, chemotherapy, radiation, and targeted therapy. Immunotherapy - also referred to as I-O therapy or cancer immuno-oncology - is showing great promise in the cancer field as a way to treat certain cancers. With “Immuno” as a reference to the immune system, immunotherapy uses drugs that target a body’s own immune system to help fight cancer. 

Although immunotherapies have been around for 30 years, significant advancements have occurred in the last year. The FDA has approved new I-O therapies for melanoma and lung cancer which are now being used to treat patients. There is enthusiasm in this area due to the significant number of patients that have had positive responses and long-lasting remissions that have not previously been seen within cancer care.

How to Access Immunotherapies

Today, the best way to access these new I-O therapies is through clinical trials. Maryland Oncology Hematology is well positioned with some of the best trials in the area. Through the support of US Oncology Research, we are often able to open clinical trials at our practice before they become available in other cancer centers. Our physicians are dedicated to learning about and shaping the newest findings in cancer treatment, and as a result, are able to extend the latest in high-quality care to our patients as soon as new options become available.